Aligos Therapeutics, Inc.ALGSNASDAQ
LOADING
|||
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
-23.21%
↓ 190% below average
Average (28q)
25.67%
Historical baseline
Range
High:600.54%
Low:-76.12%
Volatility
2636.1%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -23.21% |
| Q2 2025 | 210.29% |
| Q1 2025 | -50.56% |
| Q4 2024 | -50.43% |
| Q3 2024 | 19.60% |
| Q2 2024 | 7.61% |
| Q1 2024 | -63.22% |
| Q4 2023 | -17.23% |
| Q3 2023 | -52.96% |
| Q2 2023 | 152.88% |
| Q1 2023 | -23.01% |
| Q4 2022 | -13.86% |
| Q3 2022 | 11.18% |
| Q2 2022 | 43.64% |
| Q1 2022 | 600.54% |
| Q4 2021 | -76.12% |
| Q3 2021 | -0.52% |
| Q2 2021 | 69.78% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |